Skip to main content
. 2020 Oct 15;28(8):826–834. doi: 10.5551/jat.58297

Table 2. Changes of blood count, blood chemistry parameteres, and inflammatory and oxidative markers between the TIV+ PPSV23 and the TIV+Placebo groups.

TIV+PPSV23 ( n = 19) TIV+Placebo ( n = 21)
Baseline 4 weeks 12 weeks Baseline 4 weeks 12 weeks
Complete blood count
White blood cell count, 10 3 /mL 6.0±1.9 6.3±2.0 5.9±1.5 6.0±1.1 5.9±1.4 5.9±1.2
Hemoglobin, g/dL 14.0±2.1 14.1±2.1 14.4±1.9 14.2±1.3 14.2±1.3 14.4±1.4
Platelet, 10 3 /mL 20.1±4.7 21.4±4.5 22.0±5.1 19.3±4.2 18.2±5.0 20.5±4.1
Blood chemistry parameteres
Aspartate aminotransferase, U/L 26±12 27±13 23±8 26±13 26±11 29±17
Alanine aminotransferase, U/L 25±15 26±16 22±11 29±18 29±17 29±17
Lactate dehydrogenase, U/L 197±36 193±32 191±31 187±34 184±29 184±29
Blood urea nitrogen, g/dL 16.8±5.0 18.2±5.8 16.3±5.7 16.2±4.2 16.7±3.2 16.4±3.7
Creatinine, g/dL 0.83±0.24 0.84±0.26 0.84±0.32 0.80±0.23 0.80±0.25 0.80±0.22
Uric acid, mg/dL 5.9±0.9 6.1±1.0 6.0±0.9 5.4±1.3 5.4±1.4 5.4±1.3
Total cholesterol, mg/dL 164±25 167±20 165±21 162±29 167±32 162±23
Triglyceride, mg/dL 151±78 145±52 153±62 131±85 131±62 131±56
LDL-cholesterol, mg/dL 83±21 83±21 86±19 91±25 83±21 88±24
HDL-cholesterol, mg/dL 50±15 50±12 49±12 48±11 49±13 48±10
Fasting blood glucose, mg/dL 125±35 129±64 117±36 127±30 128±39 123±35
HbA1c, % 6.3±0.8 6.4±0.8 6.5±0.8 6.2±0.7 6.3±0.8 6.4±0.7
NT-proBNP, pg/mL 431±638 404±559 373±663 236±537 187±286 164±269
Inflammatory and oxidative markers
High-sensitivity CRP, mg/L 1.21±1.45 1.65±2.33 2.97±5.63 0.90±1.53 1.00±1.32 1.46±0.95
PTX-3, ng/mL 1.88±0.98 1.91±0.78 1.86±1.17 1.94±0.91 1.88±0.71 1.88±0.95
MDA-LDL, U/L 110±27 113±41 124±48 103±34 103±35 109±36
Anti-oxLDL, U/mL 10070±4936 5541±1773 3879±2014 **# 9410±7377 5704±1186 3540±864 **#

Values are mean±SD. INF = influenza; PC = pneumococcal; CAD = coronary artery disease; LDL = low-density lipoprotein; HDL = high-density lipoprotein; CRP = C-reactive protein; PTX = pentraxin; NT-pro BNP = N-terminal pro brain natriuretic peptide; MDA = malondialdehyde; oxLDL = oxidized LDL

P <0.05 compared with at baseline

** P <0.005 compared with at baseline

P <0.05 compared with after 4 weeks